skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 4,435  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Database: SAGE Open Access remove subject: Treatment Outcome remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial
Material Type:
Article
Add to My Research

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial

Journal of psychopharmacology (Oxford), 2018-12, Vol.32 (12), p.1295-1307 [Peer Reviewed Journal]

The Author(s) 2018 ;ISSN: 0269-8811 ;EISSN: 1461-7285 ;DOI: 10.1177/0269881118806297 ;PMID: 30371148

Digital Resources/Online E-Resources

2
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
Material Type:
Article
Add to My Research

ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

Cephalalgia, 2018-05, Vol.38 (6), p.1026-1037 [Peer Reviewed Journal]

International Headache Society 2018 ;ISSN: 0333-1024 ;EISSN: 1468-2982 ;DOI: 10.1177/0333102418759786 ;PMID: 29471679

Digital Resources/Online E-Resources

3
Ventral-Onlay Buccal Mucosal Graft Urethroplasty of a Perineal Fistula in a 26-Year-Old Patient With 46 XX Male Syndrome: A Case Report
Material Type:
Article
Add to My Research

Ventral-Onlay Buccal Mucosal Graft Urethroplasty of a Perineal Fistula in a 26-Year-Old Patient With 46 XX Male Syndrome: A Case Report

American journal of men's health, 2023-03, Vol.17 (2), p.15579883231156663-15579883231156663 [Peer Reviewed Journal]

The Author(s) 2023 ;The Author(s) 2023. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 2023 SAGE Publications Inc unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 1557-9883 ;EISSN: 1557-9891 ;DOI: 10.1177/15579883231156663 ;PMID: 37038331

Full text available

4
Semen Parameters Changes in Adolescents With Clinical Varicocele after Magnified Subinguinal Varicocelectomy: A Prospective Controlled Study
Material Type:
Article
Add to My Research

Semen Parameters Changes in Adolescents With Clinical Varicocele after Magnified Subinguinal Varicocelectomy: A Prospective Controlled Study

American journal of men's health, 2022-11, Vol.16 (6), p.15579883221141808-15579883221141808 [Peer Reviewed Journal]

The Author(s) 2022 ;The Author(s) 2022. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 2022 SAGE Publications Inc unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 1557-9883 ;EISSN: 1557-9891 ;DOI: 10.1177/15579883221141808 ;PMID: 36536998

Full text available

5
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States
Material Type:
Article
Add to My Research

Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

Journal of diabetes science and technology, 2020-07, Vol.14 (4), p.813-821 [Peer Reviewed Journal]

2020 Diabetes Technology Society ;2020 Diabetes Technology Society 2020 Diabetes Technology Society ;ISSN: 1932-2968 ;EISSN: 1932-2968 ;DOI: 10.1177/1932296820924469 ;PMID: 32389027

Full text available

6
Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
Material Type:
Article
Add to My Research

Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

Cephalalgia, 2018-07, Vol.38 (8), p.1442-1454 [Peer Reviewed Journal]

International Headache Society 2018 ;ISSN: 0333-1024 ;EISSN: 1468-2982 ;DOI: 10.1177/0333102418779543 ;PMID: 29848108

Digital Resources/Online E-Resources

7
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
Material Type:
Article
Add to My Research

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

Journal of psychopharmacology (Oxford), 2022-02, Vol.36 (2), p.151-158 [Peer Reviewed Journal]

The Author(s) 2022 ;ISSN: 0269-8811 ;EISSN: 1461-7285 ;DOI: 10.1177/02698811211073759 ;PMID: 35166158

Digital Resources/Online E-Resources

8
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
Material Type:
Article
Add to My Research

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy

European journal of preventive cardiology, 2020-04, Vol.27 (6), p.593-603 [Peer Reviewed Journal]

The European Society of Cardiology 2019 ;ISSN: 2047-4873 ;EISSN: 2047-4881 ;DOI: 10.1177/2047487319864671 ;PMID: 31357887

Digital Resources/Online E-Resources

9
Surgical correction of congenital megaprepuce: a pilot study
Material Type:
Article
Add to My Research

Surgical correction of congenital megaprepuce: a pilot study

Journal of international medical research, 2024-01, Vol.52 (1), p.3000605231218613-3000605231218613 [Peer Reviewed Journal]

The Author(s) 2024 ;The Author(s) 2024. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0300-0605 ;EISSN: 1473-2300 ;DOI: 10.1177/03000605231218613 ;PMID: 38179706

Full text available

10
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
Material Type:
Article
Add to My Research

A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine

Cephalalgia, 2016-08, Vol.36 (9), p.887-898 [Peer Reviewed Journal]

International Headache Society 2016 ;International Headache Society 2016. ;ISSN: 0333-1024 ;EISSN: 1468-2982 ;DOI: 10.1177/0333102416653233 ;PMID: 27269043

Digital Resources/Online E-Resources

11
Perceived comfort during minor hand surgeries with wide awake local anaesthesia no tourniquet (WALANT) versus local anaesthesia (LA)/tourniquet
Material Type:
Article
Add to My Research

Perceived comfort during minor hand surgeries with wide awake local anaesthesia no tourniquet (WALANT) versus local anaesthesia (LA)/tourniquet

Journal of orthopaedic surgery (Hong Kong), 2017-09, Vol.25 (3), p.2309499017739499-2309499017739499 [Peer Reviewed Journal]

The Author(s) 2017 ;2017. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2309-4990 ;ISSN: 1022-5536 ;EISSN: 2309-4990 ;DOI: 10.1177/2309499017739499 ;PMID: 29141522

Full text available

12
Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis
Material Type:
Article
Add to My Research

Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis

Multiple sclerosis, 2016-09, Vol.22 (10), p.1297-1305 [Peer Reviewed Journal]

The Author(s), 2015 ;The Author(s), 2015. ;The Author(s), 2015 2015 SAGE Publications ;ISSN: 1352-4585 ;EISSN: 1477-0970 ;DOI: 10.1177/1352458515616701 ;PMID: 26585439

Digital Resources/Online E-Resources

13
The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results
Material Type:
Article
Add to My Research

The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results

Cephalalgia, 2015-06, Vol.35 (7), p.563-578 [Peer Reviewed Journal]

International Headache Society 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav ;International Headache Society 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav. ;International Headache Society 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav 2014 International Headache Society ;ISSN: 0333-1024 ;EISSN: 1468-2982 ;DOI: 10.1177/0333102414552532 ;PMID: 25304766

Digital Resources/Online E-Resources

14
Reconstructing forked corpus spongiosum to correct glans droop in distal/midshaft hypospadias repair
Material Type:
Article
Add to My Research

Reconstructing forked corpus spongiosum to correct glans droop in distal/midshaft hypospadias repair

Journal of international medical research, 2020-05, Vol.48 (5), p.300060520925698-300060520925698 [Peer Reviewed Journal]

The Author(s) 2020 ;The Author(s) 2020. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 2020 SAGE Publications ;ISSN: 0300-0605 ;EISSN: 1473-2300 ;DOI: 10.1177/0300060520925698 ;PMID: 32459109

Full text available

15
Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study
Material Type:
Article
Add to My Research

Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study

Cephalalgia, 2018-04, Vol.38 (5), p.959-969 [Peer Reviewed Journal]

International Headache Society 2017 ;International Headache Society 2017 2017 International Headache Society ;ISSN: 0333-1024 ;EISSN: 1468-2982 ;DOI: 10.1177/0333102417744362 ;PMID: 29231763

Digital Resources/Online E-Resources

16
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
Material Type:
Article
Add to My Research

Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine

Cephalalgia, 2019-10, Vol.39 (11), p.1455-1464 [Peer Reviewed Journal]

International Headache Society 2019 ;International Headache Society 2019 2019 International Headache Society ;ISSN: 0333-1024 ;EISSN: 1468-2982 ;DOI: 10.1177/0333102419854082 ;PMID: 31146544

Digital Resources/Online E-Resources

17
Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: Results of the FIT@Home study
Material Type:
Article
Add to My Research

Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: Results of the FIT@Home study

European journal of preventive cardiology, 2017-08, Vol.24 (12), p.1260-1273 [Peer Reviewed Journal]

The European Society of Cardiology 2017 ;ISSN: 2047-4873 ;EISSN: 2047-4881 ;DOI: 10.1177/2047487317710803 ;PMID: 28534417

Digital Resources/Online E-Resources

18
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
Material Type:
Article
Add to My Research

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

Cephalalgia, 2010-07, Vol.30 (7), p.804-814 [Peer Reviewed Journal]

International Headache Society 2010. Published by SAGE. All rights reserved. SAGE Publications ;ISSN: 0333-1024 ;EISSN: 1468-2982 ;DOI: 10.1177/0333102410364677 ;PMID: 20647171

Digital Resources/Online E-Resources

19
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)
Material Type:
Article
Add to My Research

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)

Cephalalgia, 2018-05, Vol.38 (6), p.1038-1048 [Peer Reviewed Journal]

International Headache Society 2018 ;International Headache Society 2018 2018 International Headache Society ;ISSN: 0333-1024 ;EISSN: 1468-2982 ;DOI: 10.1177/0333102418762525 ;PMID: 29504483

Digital Resources/Online E-Resources

20
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
Material Type:
Article
Add to My Research

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

Cephalalgia, 2010-07, Vol.30 (7), p.793-803 [Peer Reviewed Journal]

International Headache Society 2010. Published by SAGE. All rights reserved. SAGE Publications ;ISSN: 0333-1024 ;EISSN: 1468-2982 ;DOI: 10.1177/0333102410364676 ;PMID: 20647170

Digital Resources/Online E-Resources

Results 1 - 20 of 4,435  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1997  (53)
  2. 1997 To 2002  (274)
  3. 2003 To 2008  (894)
  4. 2009 To 2015  (1,554)
  5. After 2015  (1,661)
  6. More options open sub menu

Language 

  1. English  (4,434)
  2. Japanese  (370)
  3. Norwegian  (5)
  4. French  (2)
  5. Danish  (1)
  6. Russian  (1)
  7. More options open sub menu

Searching Remote Databases, Please Wait